Sperry Bio is a Health Care startup founded in 2019 with a slogan of "Empowering regenerative skin medicine innovations for military medical research." The company offers the Sperry Micro-Coring System, a groundbreaking medical device that is yet to receive marketing clearance. This innovative solution is aligned with the prioritized goals of regenerative skin medicine research programs under the Army Medical Research and Materiel Command's Clinical and Rehabilitative Medicine Research Initiatives. The latest investment round saw a significant injection, with $255.38K received in a corporate round from the National Science Foundation on 18 February 2021. This funding is testament to the potential of Sperry Bio's technology and its promising role in advancing regenerative skin medicine, particularly for military medical research. The company shows promise in contributing to the advancement of medical research and care, with a strong focus on regenerative medicine.
No recent news or press coverage available for Sperry Bio.